Your browser doesn't support javascript.
loading
Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma.
Aya, F; Fernandez-Martinez, A; Gaba, L; Victoria, I; Tosca, M; Pineda, E; Gascon, P; Prat, A; Arance, A.
Afiliación
  • Aya F; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. faya@clinic.ub.es.
  • Fernandez-Martinez A; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. faya@clinic.ub.es.
  • Gaba L; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Victoria I; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Tosca M; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Pineda E; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Gascon P; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Arance A; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
Clin Transl Oncol ; 19(1): 119-124, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27147251
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Inmunoterapia / Melanoma / Anticuerpos Monoclonales / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Año: 2017 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Inmunoterapia / Melanoma / Anticuerpos Monoclonales / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Año: 2017 Tipo del documento: Article País de afiliación: España